Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient

Abstract

Abstract A 43‐year‐old man who was treated with interferon‐beta for multiple sclerosis was presented with hypertension, headache, nausea/vomiting, blurred vision, and renal dysfunction. The treatment with drugs and dialysis relieved the symptoms. Despite plasmapheresis is known to cause improvement in renal function, no such improvement was seen in patient.

Keywords

• interferon‐beta
• multiple sclerosis
• thrombotic microangiopathy